Search

everythinglearnresearchcommunity

for

Search:↓

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Trichotillomania was successfully treated with risperidone and naltrexone.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Thyroid receptor β can help develop new drugs to treat hair loss.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

The combination therapy was effective and well-tolerated, especially in young patients.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

AVT is highly conserved and may have antimicrobial properties.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Tridax procumbens may help treat diabetes.

Certain alkaloids could help create new coronavirus drugs.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

MR antagonists may improve skin health and wound healing, especially in aging.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.